Literature DB >> 12229962

Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.

S J Konturek1, T Starzynska, P C Konturek, E Karczewska, K Marlicz, M Lawniczak, H Jaroszewicz-Heigelman, W Bielanski, A Hartwich, A Ziemniak, E G Hahn.   

Abstract

BACKGROUND: Despite numerous epidemiological studies, the association between Helicobacter pylori infection and gastric cancer (GC) remains unexplained. This study was designed to determine the seropositivity of H. pylori and cytotoxin-associated gene A (CagA), serum gastrin and interleukin-8 (IL-8) levels as well as basal intragastric pH and maximal histamine-induced gastric acid outputs (MAO) in a large series of GC patients and controls.
METHODS: 337 GC patients (118 men and 219 women; median age 59.4; range 21-87) and 337 controls randomized for sex and age entered the study. Serum IgG antibodies to H. pylori and CagA and serum levels of IL-8 were measured by enzyme-linked immunosorbent assay, while serum-amidated gastrin was determined by specific radioimmunoassay and correlated with gastric luminal pH.
RESULTS: The numbers of GC patients and controls involved in the study in various age groups, ranging from 20 to > 70 years, were similar, but overall H. pylori IgG seropositivity in GC patients was significantly higher (90.8%) than in controls (79.2%). The overall CagA seropositivity in GC patients was about double (58.2%) that in controls (25.2%). Serum gastrin levels over the calculated cut-off value (38.88 pM/L) were found in several-fold larger number in GC patients (48%) than in controls (8.3%) and. similarly, serum IL-8 values over the cut-off point (1.77 pg/mL) occurred in almost all (99.7%) GC patients but in only a few controls (0.3%). Basal intragastric pH above the cut-off point (pH = 4.50) was observed in about 58.2% of GC patients compared to 15.1% in controls, and strong correlation between the serum gastrin and gastric pH was found in GC but weak in controls. The cut-off value for MAO was 12.3 mml/h; MAO below this cut-off value occurred in 89.9% of GC patients and in only 4.7% of controls. A summary odds ratio (SOR) in GC for H. pylori IgG was 2.59 (95% Cl: 1.61-4.22) for CagA - 4.12 (95% Cl; 2.93-5.8), for serum gastrin - 10.25 (95%; 6.47-16.47) and for MAO - 15.2 (95% Cl; 9.45-39.82). Multivariable analysis of serum gastrin, IgG and CagA, and luminal pH and MAO values revealed that only gastrin and CagA have significant influence on GC formation (OR > 1 in logistic regression).
CONCLUSIONS: 1. CG patients show significantly higher H. pylori IgG and CagA seropositivity than dyspeptic age- and gender-matched controls, confirming that gastric infection with CagA expressing H. pylori greatly increases the risk of GC. 2. Serum gastrin levels in GC but not in controls are correlated with the rise in intragastric pH, indicating that excessive gastrin release in GC is affected by lower intragastric pH. 3. Serum gastrin level and CagA seropositivity are significantly increased in the majority of GC patients, and are the only variables in multivariable analysis to have a predominant influence on GC formation, which suggests that both these parameters may be implicated in H. pylori-related gastric carcinogenesis. 4. H. pylori-infected GC patients produce significantly more IL-8 than do non-GC controls, probably reflecting CagA-positive H. pylori-associated gastritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12229962     DOI: 10.1080/003655202760230838

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  15 in total

Review 1.  Diet, H pylori infection and gastric cancer: evidence and controversies.

Authors:  Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

2.  Helicobacter pylori infection and colorectal carcinoma: is there a causal association?

Authors:  Sergei F Tatishchev; Christine Vanbeek; Hanlin L Wang
Journal:  J Gastrointest Oncol       Date:  2012-12

3.  Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.

Authors:  M H Derakhshan; E El-Omar; K Oien; D Gillen; V Fyfe; J E Crabtree; K E L McColl
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

4.  Circulating cytokines and gastric cancer risk.

Authors:  Meira Epplein; Yong-Bing Xiang; Qiuyin Cai; Richard M Peek; Honglan Li; Pelayo Correa; Jing Gao; Jie Wu; Angelika Michel; Michael Pawlita; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer Causes Control       Date:  2013-09-20       Impact factor: 2.506

5.  Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.

Authors:  Johanna C Sierra; Mohammad Asim; Thomas G Verriere; M Blanca Piazuelo; Giovanni Suarez; Judith Romero-Gallo; Alberto G Delgado; Lydia E Wroblewski; Daniel P Barry; Richard M Peek; Alain P Gobert; Keith T Wilson
Journal:  Gut       Date:  2017-05-04       Impact factor: 23.059

6.  Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China.

Authors:  Xiangting Zeng; Yumin Li; Tao Liu; Junqiang Zhang
Journal:  Mol Cell Biochem       Date:  2011-11-13       Impact factor: 3.396

7.  Human gastrin mRNA expression up-regulated by Helicobacter pylori CagA through MEK/ERK and JAK2-signaling pathways in gastric cancer cells.

Authors:  Jianjiang Zhou; Yuan Xie; Yan Zhao; Shu Wang; Yu Li
Journal:  Gastric Cancer       Date:  2011-04-22       Impact factor: 7.370

Review 8.  Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 9.  Novel role of toll-like receptors in Helicobacter pylori - induced gastric malignancy.

Authors:  Kaname Uno; Katsuaki Kato; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

10.  Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.

Authors:  Mesfin Esayas Lelisho; Geremew Muleta Akessa; Demeke Kifle Demissie; Samuel Fikadu Yermosa; Solomon Abebaw Andargie; Seid Ali Tareke; Digvijay Pandey
Journal:  J Gastrointest Cancer       Date:  2022-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.